#AHA17: A Twitter Roundup
In This Article
- Health care professionals at this year's American Heart Association's Scientific Sessions talked research, treatment approaches and guidelines on the podium and in conference halls
- These conversations carried over onto Twitter, with nearly 200 million impressions and over 30,000 #AHA17 tweets
Healthcare professionals at this year’s American Heart Association’s Scientific Sessions discussed late-breaking research, innovative treatment approaches and brand new guidelines. The conversations carried over from the podium and conference halls onto Twitter, with nearly 200 million impressions and over 30,000 tweets.
Subscribe to the latest updates from Cardiovascular Advances in Motion
Here is a list of some noteworthy #AHA17 tweets.
New Hypertension Guideline
The American Heart Association created buzz on Twitter and beyond with the announcement of their new hypertension guideline.
Is your blood pressure under control? If it’s higher than 130/80, your doctor may want to take a closer look. #AHA17 pic.twitter.com/rIKbdxogZQ
— American Heart Assoc (@American_Heart) November 13, 2017
Poster Presentation
Mass General's Brian Ghoshhajra, MD, shared a poster by Jan-Erik Scholtz, MD, demonstrating improved results by following the newly revised 2017 Fleischner Society Guidelines.
No one likes unnecessarily following incidental lung nodules. @JanErikScholtz congrats on your #AHA17 poster showing a 64.5% decrease in followup needed for ED #CCTA scans by switching to the new 2017 Fleischner guidelines. pic.twitter.com/gZiEAs4Cpx
— Brian Ghoshhajra, MD (@ghoshhajra) November 14, 2017
A Systematic Review
JAMA released a systematic review showing the association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected ACS.
High-sensitivity cardiac Troponin I & cardiac outcomes in suspected acute coronary syndrome https://t.co/o1SUtdLTIL #AHA17
— JAMA (@JAMA_current) November 11, 2017
Lifetime Risk of Atrial Fibrillation
Mass General's Steven Lubitz, MD, noted that the lifetime risk of atrial fibrillation in the Framingham Heart Study is around 37% after the age of 55.
Lifetime risk of #AFib in Framingham Heart Study ~37% after age 55yrs @LuChenWeng @EmeliaBenjamin @MGHHeartHealth #AHA2017 https://t.co/o30kKSfpGi pic.twitter.com/Db4NzIvMSl
— Steven Lubitz (@steven_lubitz) November 13, 2017
The Fight Against Coronary Disease
Mass General's Jason Wasfy, MD, offered his well wishes to American Heart Association President John Warner, MD, as he recovers from a myocardial infarction, and reminded his followers of the work ahead to fight coronary disease.
Sad news although grateful to know that Dr Warner is doing well.
— Jason H. Wasfy, M.D. (@jasonwasfy) November 14, 2017
Reminds all of us of the work ahead to fight coronary disease! #AHA17 https://t.co/D30ITAPfIs
Distinguished Scientist Award
Mass General's Sekar Kathiresan, MD, who was named an American Heart Association Distinguished Scientist at #AHA17, thanked his family, friends and followers for their kind words in response to his achievement.
Tweeps,
— Sek Kathiresan MD (@skathire) November 13, 2017
Thank you very much for kind words. Grateful to my family, mentors, trainees, institutions, and to this great country.
From immigration 1980 with my brother (L) to #AHA17 honor of our scientific contributions yesterday (R).
A testament to power of opportunity in ???? pic.twitter.com/EPAsBCacV8
Do you use Twitter to disseminate innovative treatment approaches and new data? Tell us about your experience with social media as a platform for discussing research in the comments below.
Refer a patient to the Corrigan Minehan Heart Center